CAS 910463-68-2

Semaglutide

Description:

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) analog, primarily used in the management of type 2 diabetes and obesity. It is characterized by its ability to enhance insulin secretion in response to elevated blood glucose levels, thereby aiding in glycemic control. Semaglutide has a long half-life due to its resistance to enzymatic degradation, which allows for once-weekly subcutaneous administration. The substance is typically administered as a solution for injection and is known for its efficacy in promoting weight loss in addition to its glucose-lowering effects. Its mechanism of action involves stimulating insulin release, inhibiting glucagon secretion, and slowing gastric emptying, which collectively contribute to improved metabolic outcomes. Semaglutide is also associated with a favorable safety profile, although it may have side effects such as gastrointestinal disturbances. As a peptide drug, it is composed of 31 amino acids and has a molecular weight that reflects its complex structure. Overall, semaglutide represents a significant advancement in diabetes and obesity treatment options.

Synonyms:

• Sermaglutide

Semaglutide

CAS: 910463-68-2

Acylated GLP-1 analog with a half-life of 160 h. Semaglutide is under evaluation for the management of diabetes II. Due to its prolonged half-life, the peptide has to be injected only once per week. Bachem provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Bachem against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Purity: 97.5%

Color and Shape: White

Molecular weight: 4113.64

Ref: 01-4091661

Semaglutide

CAS: 910463-68-2

Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Purity: 99%

Color and Shape: Solid

Molecular weight: 4113.5775

Ref: IN-DA00H230

Semaglutide-d8

CAS: 910463-68-2

Formula: C₁₈₇H₂₈₃D₈N₄₅O₅₉

Molecular weight: 4121.69

Ref: 4Z-PS-189038

Semaglutide-d8 Tetratrifluoroacetate

CAS: 910463-68-2

Formula: C₁₈₇H₂₈₃D₈N₄₅O₅₉·4C₂HF₃O₂

Color and Shape: White To Off-White Solid

Molecular weight: 4121.69 4*114.02

Ref: 4Z-PS-189003

Semaglutide

CAS: 910463-68-2

Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Color and Shape: White To Off-White Solid

Molecular weight: 4113.64

Ref: 4Z-PS-189002

Semaglutide-d15 Tetratrifluoroacetate

CAS: 910463-68-2

Formula: C₁₈₇H₂₇₆D₁₅N₄₅O₅₉·4C₂HF₃O₂

Molecular weight: 4128.73 4*114.02

Ref: 4Z-PS-189004

Semaglutide

CAS: 910463-68-2

Purity: ≥ 98.0%

Color and Shape: White powder

Ref: 7W-GW8695

Semaglutide

CAS: 910463-68-2

Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).

Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Purity: 96.92% - 99.78%

Color and Shape: Solid

Molecular weight: 4114

Ref: TM-T19850

Semaglutide . AcOH

CAS: 910463-68-2

Purity: ≥ 98.0%

Color and Shape: Solid lyophilized powder

Ref: 7W-GW1848

Semaglutide-13C16,15N4

CAS: 910463-68-2

Formula: C₁₇₁₁C₁₆H₂₉₁N₄₁₁₅N₄O₅₉

Molecular weight: 4133.49

Ref: 4Z-PS-189050

Semaglutide

CAS: 910463-68-2

Anti-diabetic and anti-obesity drug.  We also have the heavy labelled material, CRB1301886. Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Purity: Min. 99.0 Area-%

Color and Shape: Powder

Molecular weight: 4,113.58 g/mol

Ref: 3D-FS171058

Semaglutide sodium

CAS: 910463-68-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Formula: C₁₈₇H₂₉₁N₄₅O₅₉•Nax

Purity: Min. 98.0 Area-%

Color and Shape: Powder

Molecular weight: 4,113.58 g/mol

Ref: 3D-BS182652